Literature DB >> 24668547

Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A.

Fernanda Wisnieski1, Danielle Queiroz Calcagno, Mariana Ferreira Leal, Elizabeth Suchi Chen, Carolina Oliveira Gigek, Leonardo Caires Santos, Thaís Brilhante Pontes, Lucas Trevizani Rasmussen, Spencer Luiz Marques Payão, Paulo Pimentel Assumpção, Laércio Gomes Lourenço, Sâmia Demachki, Ricardo Artigiani, Rommel Rodríguez Burbano, Marília Cardoso Smith.   

Abstract

Gastric cancer is still the second leading cause of cancer-related death worldwide, even though its incidence and mortality have declined over the recent few decades. Epigenetic control using histone deacetylase inhibitors, such as trichostatin A (TSA), is a promising cancer therapy. This study aimed to assess the messenger RNA (mRNA) levels of three histone deacetylases (HDAC1, HDAC2, and HDAC3), two histone acetyltransferases (GCN5 and PCAF), and two possible targets of these histone modifiers (MYC and CDKN1A) in 50 matched pairs of gastric tumors and corresponding adjacent nontumors samples from patients with gastric adenocarcinoma, as well as their correlations and their possible associations with clinicopathological features. Additionally, we evaluated whether these genes are sensitive to TSA in gastric cancer cell lines. Our results demonstrated downregulation of HDAC1, PCAF, and CDKN1A in gastric tumors compared with adjacent nontumors (P < 0.05). On the other hand, upregulation of HDAC2, GCN5, and MYC was observed in gastric tumors compared with adjacent nontumors (P < 0.05). The mRNA level of MYC was correlated to HDAC3 and GCN5 (P < 0.05), whereas CDKN1A was correlated to HDAC1 and GCN5 (P < 0.05 and P < 0.01, respectively). In addition, the reduced expression of PCAF was associated with intestinal-type gastric cancer (P = 0.03) and TNM stages I/II (P = 0.01). The increased expression of GCN5 was associated with advanced stage gastric cancer (P = 0.02) and tumor invasion (P = 0.03). The gastric cell lines treated with TSA showed different patterns of histone deacetylase and acetyltransferase mRNA expression, downregulation of MYC, and upregulation of CDKN1A. Our findings suggest that alteration of histone modifier genes play an important role in gastric carcinogenesis, contributing to MYC and CDKN1A deregulation. In addition, all genes studied here are modulated by TSA, although this modulation appears to be dependent of the genetic background of the cell line.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24668547     DOI: 10.1007/s13277-014-1841-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  66 in total

Review 1.  Structure and function of histone acetyltransferases.

Authors:  R Marmorstein
Journal:  Cell Mol Life Sci       Date:  2001-05       Impact factor: 9.261

2.  Reference genes for quantitative RT-PCR data in gastric tissues and cell lines.

Authors:  Fernanda Wisnieski; Danielle Queiroz Calcagno; Mariana Ferreira Leal; Leonardo Caires dos Santos; Carolina de Oliveira Gigek; Elizabeth Suchi Chen; Thaís Brilhante Pontes; Paulo Pimentel Assumpção; Mônica Barauna de Assumpção; Sâmia Demachki; Rommel Rodríguez Burbano; Marília de Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

3.  The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60.

Authors:  Jagruti H Patel; Yanping Du; Penny G Ard; Charles Phillips; Beth Carella; Chi-Ju Chen; Carrie Rakowski; Chandrima Chatterjee; Paul M Lieberman; William S Lane; Gerd A Blobel; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 4.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

Review 5.  Genetic pathways of two types of gastric cancer.

Authors:  Eiichi Tahara
Journal:  IARC Sci Publ       Date:  2004

6.  Expression profile of class I histone deacetylases in human cancer tissues.

Authors:  Masamune Nakagawa; Yoshinao Oda; Takashi Eguchi; Shin-Ichi Aishima; Takashi Yao; Fumihito Hosoi; Yuji Basaki; Mayumi Ono; Michihiko Kuwano; Masao Tanaka; Masazumi Tsuneyoshi
Journal:  Oncol Rep       Date:  2007-10       Impact factor: 3.906

Review 7.  Histone deacetylase inhibitors: multifunctional anticancer agents.

Authors:  Tao Liu; Selena Kuljaca; Andrew Tee; Glenn M Marshall
Journal:  Cancer Treat Rev       Date:  2006-03-03       Impact factor: 12.111

8.  TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription.

Authors:  Niall S Kenneth; Ben A Ramsbottom; Natividad Gomez-Roman; Lynne Marshall; Philip A Cole; Robert J White
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

9.  Expression profile of histone deacetylase 1 in gastric cancer tissues.

Authors:  J H Choi; H J Kwon; B I Yoon; J H Kim; S U Han; H J Joo; D Y Kim
Journal:  Jpn J Cancer Res       Date:  2001-12

10.  Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program.

Authors:  V Sartorelli; P L Puri; Y Hamamori; V Ogryzko; G Chung; Y Nakatani; J Y Wang; L Kedes
Journal:  Mol Cell       Date:  1999-11       Impact factor: 17.970

View more
  16 in total

1.  Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma.

Authors:  Wenxing Fan; Jie Huang; Hua Xiao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.

Authors:  Ziliang Jin; Weihua Jiang; Feng Jiao; Zhen Guo; Hai Hu; Lei Wang; Liwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 3.  KATapulting toward Pluripotency and Cancer.

Authors:  Calley L Hirsch; Jeffrey L Wrana; Sharon Y R Dent
Journal:  J Mol Biol       Date:  2016-10-06       Impact factor: 5.469

4.  The effects of anticancer drugs TSA and GSK on spermatogenesis in male mice.

Authors:  Wen-Yan Song; Qing-Ling Yang; Wan-Li Zhao; Hai-Xia Jin; Gui-Dong Yao; Zhao-Feng Peng; Sen-Lin Shi; Hong-Yi Yang; Xiang-Yang Zhang; Ying-Pu Sun
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

5.  CDKN1A histone acetylation and gene expression relationship in gastric adenocarcinomas.

Authors:  Fernanda Wisnieski; Danielle Queiroz Calcagno; Mariana Ferreira Leal; Leonardo Caires Santos; Carolina Oliveira Gigek; Elizabeth Suchi Chen; Sâmia Demachki; Ricardo Artigiani; Paulo Pimentel Assumpção; Laércio Gomes Lourenço; Rommel Rodríguez Burbano; Marília Cardoso Smith
Journal:  Clin Exp Med       Date:  2015-11-14       Impact factor: 3.984

6.  Differential regulation of LRRC37A2 in gastric cancer by DNA methylation.

Authors:  Fernanda Wisnieski; Jaqueline Cruz Geraldis; Leonardo Caires Santos; Mariana Ferreira Leal; Danielle Queiroz Calcagno; Carolina Oliveira Gigek; Elizabeth Suchi Chen; Ana Carolina Anauate; Ricardo Artigiani; Samia Demachki; Paulo Pimentel Assumpção; Laercio Gomes Lourenço; Carlos Haruo Arasaki; Julie Krainer; Stephan Pabinger; Rommel Rodriguez Burbano; Marilia Arruda Cardoso Smith
Journal:  Epigenetics       Date:  2021-02-08       Impact factor: 4.528

Review 7.  Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.

Authors:  Omeima Abdullah; Ziad Omran; Salman Hosawi; Ali Hamiche; Christian Bronner; Mahmoud Alhosin
Journal:  Genes (Basel)       Date:  2021-04-22       Impact factor: 4.096

8.  Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.

Authors:  Dongfang Tang; Yu Chen Zhao; Danwen Qian; Hongliang Liu; Sheng Luo; Edward F Patz; Patricia G Moorman; Li Su; Sipeng Shen; David C Christiani; Carolyn Glass; Wen Gao; Qingyi Wei
Journal:  Mol Carcinog       Date:  2019-11-12       Impact factor: 5.139

Review 9.  Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer.

Authors:  Kelly Cristina da Silva Oliveira; Taíssa Maíra Thomaz Araújo; Camila Inagaki Albuquerque; Gabriela Alcantara Barata; Carolina Oliveira Gigek; Mariana Ferreira Leal; Fernanda Wisnieski; Fernando Augusto Rodrigues Mello Junior; André Salim Khayat; Paulo Pimentel de Assumpção; Rommel Mário Rodriguez Burbano; Marília Cardoso Smith; Danielle Queiroz Calcagno
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

10.  MicroRNA-31 Function as a Suppressor Was Regulated by Epigenetic Mechanisms in Gastric Cancer.

Authors:  Jun Wei; Zijian Wang; Zhixiang Wang; Yong Yang; Changlai Fu; Jianqing Zhu; Danbin Jiang
Journal:  Biomed Res Int       Date:  2017-12-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.